Savitha M. Rao

Array ( [id] => 5954556 [patent_doc_number] => 20110034564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'SOLUBLE COMPLEXES OF CURCUMIN' [patent_app_type] => utility [patent_app_number] => 12/857122 [patent_app_country] => US [patent_app_date] => 2010-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9071 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034564.pdf [firstpage_image] =>[orig_patent_app_number] => 12857122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382593 [patent_doc_number] => 20120226217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'PHOTOSENSITIZING COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/390404 [patent_app_country] => US [patent_app_date] => 2010-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8425 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039468 [patent_doc_number] => 20110092517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Use of PPAR Delta Ligands for the Treatment or Prevention of Inflammation or Energy Metabolism/Production Related Diseases' [patent_app_type] => utility [patent_app_number] => 12/856532 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 47685 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092517.pdf [firstpage_image] =>[orig_patent_app_number] => 12856532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8324444 [patent_doc_number] => 20120196858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'METHOD OF PROMOTING APOPTOSIS AND INHIBITING METASTASIS' [patent_app_type] => utility [patent_app_number] => 13/389417 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13652 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239255 [patent_doc_number] => 08604047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Method and composition for treating nodulocystic and conglobate acne vulgaris' [patent_app_type] => utility [patent_app_number] => 12/854033 [patent_app_country] => US [patent_app_date] => 2010-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1367 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12854033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026548 [patent_doc_number] => 08536130 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Use of 1 phenyl-3-dimethylamino-propane compounds for treating neuropathic pain' [patent_app_type] => utility [patent_app_number] => 12/850208 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7413 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12850208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954299 [patent_doc_number] => 20110034489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'SOLID DOSAGE FORMS OF HIV PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/848310 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4841 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034489.pdf [firstpage_image] =>[orig_patent_app_number] => 12848310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8503220 [patent_doc_number] => 20120302629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'BIOMARKERS FOR GOSSYPOL CHEMOTHERAPY AND METHODS OF TREATING DISEASE' [patent_app_type] => utility [patent_app_number] => 13/388610 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 25870 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929867 [patent_doc_number] => 20110039826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER AND OTHER DISEASES OR DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/844920 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8746 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039826.pdf [firstpage_image] =>[orig_patent_app_number] => 12844920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313622 [patent_doc_number] => 20120190646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'Compositions Comprising Thalidomide and Artemisinin for the Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 13/386890 [patent_app_country] => US [patent_app_date] => 2010-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5394 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148677 [patent_doc_number] => 20110020272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'COMBINATION THERAPY FOR TREATING HEPATITIS VIRAL INFECTION' [patent_app_type] => utility [patent_app_number] => 12/843650 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 58305 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020272.pdf [firstpage_image] =>[orig_patent_app_number] => 12843650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177534 [patent_doc_number] => 20110178049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'AVERMECTIN/HYDROCORTISONE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN. E.G., ROSACEA' [patent_app_type] => utility [patent_app_number] => 12/843372 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2431 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178049.pdf [firstpage_image] =>[orig_patent_app_number] => 12843372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9223580 [patent_doc_number] => 20140018354 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2014-01-16 [patent_title] => 'INHIBITORS OF MTOR KINASE AS ANTI-VIRAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/386547 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 41552 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9223580 [patent_doc_number] => 20140018354 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2014-01-16 [patent_title] => 'INHIBITORS OF MTOR KINASE AS ANTI-VIRAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/386547 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 41552 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952243 [patent_doc_number] => 20110033395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA' [patent_app_type] => utility [patent_app_number] => 12/834095 [patent_app_country] => US [patent_app_date] => 2010-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2390 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033395.pdf [firstpage_image] =>[orig_patent_app_number] => 12834095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600250 [patent_doc_number] => 20100322870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'METHOD FOR TREATING OR PREVENTING THROMBOSIS USING DABIGATRAN ETEXILATE OR A SALT THEREOF WITH IMPROVED EFFICACY OVER CONVENTIONAL WARFARIN THERAPY' [patent_app_type] => utility [patent_app_number] => 12/817369 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21881 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322870.pdf [firstpage_image] =>[orig_patent_app_number] => 12817369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600235 [patent_doc_number] => 20100322869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'METHOD FOR TREATING OR PREVENTING THROMBOSIS USING DABIGATRAN ETEXILATE OR A SALT THEREOF WITH IMPROVED SAFETY PROFILE OVER CONVENTIONAL WARFARIN THERAPY' [patent_app_type] => utility [patent_app_number] => 12/817347 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22238 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322869.pdf [firstpage_image] =>[orig_patent_app_number] => 12817347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10864030 [patent_doc_number] => 08889729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'Compositions for treating amyloid associated diseases' [patent_app_type] => utility [patent_app_number] => 12/794746 [patent_app_country] => US [patent_app_date] => 2010-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 13795 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12794746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8251889 [patent_doc_number] => 20120156212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING NEOPLASIA' [patent_app_type] => utility [patent_app_number] => 13/322842 [patent_app_country] => US [patent_app_date] => 2010-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14936 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156212.pdf [firstpage_image] =>[orig_patent_app_number] => 13322842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9245412 [patent_doc_number] => 08609693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Methods of administration of thrombopoietin agonist compounds' [patent_app_type] => utility [patent_app_number] => 13/321577 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5824 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321577 [rel_patent_id] =>[rel_patent_doc_number] =>)